ClearOne is trading 5.2% down at $6.02 after announcing agreements to issue 855,000 shares to four advisors for services connected to its pending Cortigent merger.
- The issuance adds dilution concerns alongside the planned 12.5 million-share consideration to Vivani Medical.
- ClearOne fell 29.29% during the August 11 regular session amid recent merger-driven volatility.
- The filing does not explicitly attribute the after-hours decline to the announcement.